Researchers have published a peer-reviewed study of two Sinopharm COVID-19 vaccines - with the results showing strong efficacy in protecting against COVID-19.
The findings were published overnight in the Journal of the American Medical Association after more than 40,000 volunteers were given either a placebo, or one of two vaccines.
The two inactivated vaccines showed 72.8 per cent and 78.1 per cent efficacy.
The report concluded: "Treatment of adults with either of 2 inactivated SARS-CoV-2 vaccines significantly reduced the risk of symptomatic COVID-19, and serious adverse events were rare."
None of the volunteers given an active vaccine developed severe disease, compared with two of those given placebo.
The study was completed by researchers in Wuhan, China, and the UAE, including Dr Nawal Al Kaabi of the Abu Dhabi Health Services Company, (SEHA).
UAE announces suspension of Iranian airlines' flights
10 million meals for Gaza in tribute to late Sheikh Ahmed bin Rashid
UAE steps up winter relief efforts for Gaza families
Sheikh Abdullah meets President of Ecuador on UNGA81 sidelines
Dubai Police trains school bus drivers and supervisors on student safety
H.H. Sheikh Mohammed receives condolences on passing of Sheikh Ahmed
UAE welcomes US statement on Sudan peace efforts
UAE among global leaders in nuclear security progress
